As populations age and hospitalization and long-term care become more common, healthcare-associated infections (HAIs), including many caused by drug-resistant pathogens, are increasing in importance and pose a significant threat to patient safety.
Business & Economics
By Sue Barnes, RN, CIC, FAPIC
Economic evaluations of interventions to prevent healthcare-associated infections in the United States rarely take the societal perspective and thus ignore the potential benefits of morbidity and mortality risk reductions.
Implementation of the Hospital Readmissions Reduction Program Associated With Increase in Patient-Level Mortality
A policy designed to reduce hospital readmissions through financial penalties was associated with a significant increase in post-discharge mortality for patients with heart failure and pneumonia, according to a large-scale study by researchers in Beth Israel Deaconess Medical Center’s (BIDMC) Smi
ISPOR, the professional society for health economics and outcomes research, announced today the publication of new recommendations for economic analysis of vaccination programs given limited resources and budgets.
A major goal of hospitals is to prevent unplanned re-admissions of patients after they are discharged.
Hospitals may have avoided financial penalties by billing hospital-associated conditions (HAC) as present at the time of the patient’s admission, supporting prior work that showed that a Medicare policy designed to monetarily penalize hos
By Kelly M. Pyrek
Editor's note: This is the first in a series of articles exploring imperatives relating to the research, behavioral and implementation sciences of infection prevention.
A new study from the Center for Disease Dynamics, Economics & Policy (CDDEP), with collaborators from Johns Hopkins University and University of Texas Southwestern Medical Center, found that infections caused by one of the most common